Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
Hong Kong · Delayed Price · Currency is HKD 4.800
-0.140 (-2.83%)
Jul 10, 2026, 9:44 AM HKT
HKG:1167 Market Cap
HKG:1167 has a market cap or net worth of 3.87 billion as of July 9, 2026. Its market cap has decreased by -8.47% in one year.
Market Cap
3.87B
Enterprise Value
2.79B
Revenue
59.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.80
Market Cap Chart
Since December 21, 2020, HKG:1167's market cap has decreased from 10.95B to 3.87B, a decrease of -64.68%. That is a compound annual growth rate of -17.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 3.87B | -22.82% |
| Dec 31, 2025 | 5.01B | 400.46% |
| Dec 31, 2024 | 1.00B | -65.05% |
| Dec 29, 2023 | 2.87B | -28.96% |
| Dec 30, 2022 | 4.03B | -63.93% |
| Dec 31, 2021 | 11.19B | 3.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TransThera Sciences (Nanjing) | 4.36B |
| Ocumension Therapeutics | 3.99B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.53B |
| Guangzhou Innogen Pharmaceutical Group | 3.50B |
| Medtide | 3.20B |
| Jiangsu Recbio Technology | 3.19B |
| Shandong Boan Biotechnology | 3.09B |